Skip to Content

RA33 (Pantoprazole Sodium Delayed-Release 20 mg)

Pill with imprint RA33 is Yellow, Elliptical / Oval and has been identified as Pantoprazole Sodium Delayed-Release 20 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..

Pantoprazole is used in the treatment of barrett's esophagus; dumping syndrome; gerd; duodenal ulcer; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RA33

Pantoprazole Sodium Delayed-Release

Imprint:
RA33
Strength:
20 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC):
63304-0967

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide